 | • レポートコード：MRC2012B0759 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、投薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。投薬の種類別市場規模（ブランド医薬品、ジェネリック医薬品）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Gilead Sciences、Johnson & Johnson、Roche、AbbVie、Sanofi、Amgen、Novartis、Merck & Co. (MSD)、GlaxoSmithKline (GSK)、Bayer、Takeda、AstraZeneca、Takeda、Novo Nordisk、Teva、Bristol-Myers Squibb、Boehringer Ingelheim、Allergan、Eli Lilly、 ・地域別グローバル市場分析 2015年-2020年 ・投薬の北米市場（アメリカ、カナダ、メキシコ） ・投薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・投薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・投薬の南米市場（ブラジル、アルゼンチン） ・投薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ブランド医薬品、ジェネリック医薬品 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Medication market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Medication market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Medication market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Medication market has been segmented into:
Brand Drugs
Generic Drug
By Application, Medication has been segmented into:
Hospital
Clinic
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Medication market presented in the report. This section sheds light on the sales growth of different regional and country-level Medication markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Medication market.
The report offers in-depth assessment of the growth and other aspects of the Medication market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Medication Market Share Analysis
Medication competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Medication sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Medication sales, revenue and market share for each player covered in this report.
The major players covered in Medication are:
Pfizer
Gilead Sciences
Johnson & Johnson
Roche
AbbVie
Sanofi
Amgen
Novartis
Merck & Co. (MSD)
GlaxoSmithKline (GSK)
Bayer
Takeda
AstraZeneca
Takeda
Novo Nordisk
Teva
Bristol-Myers Squibb
Boehringer Ingelheim
Allergan
Eli Lilly
Table of Contents
1 Medication Market Overview
1.1 Product Overview and Scope of Medication
1.2 Classification of Medication by Type
1.2.1 Global Medication Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Medication Revenue Market Share by Type in 2019
1.2.3 Brand Drugs
1.2.4 Generic Drug
1.3 Global Medication Market by Application
1.3.1 Overview: Global Medication Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Medication Market by Regions
1.4.1 Global Medication Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Medication (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Medication Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Medication Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Medication Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Medication Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Medication Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Medication Revenue, Gross Margin and Market Share (2018-2019)
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Gilead Sciences SWOT Analysis
2.2.4 Gilead Sciences Product and Services
2.2.5 Gilead Sciences Medication Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Medication Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Medication Revenue, Gross Margin and Market Share (2018-2019)
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AbbVie SWOT Analysis
2.5.4 AbbVie Product and Services
2.5.5 AbbVie Medication Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Medication Revenue, Gross Margin and Market Share (2018-2019)
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Amgen SWOT Analysis
2.7.4 Amgen Product and Services
2.7.5 Amgen Medication Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Medication Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck & Co. (MSD)
2.9.1 Merck & Co. (MSD) Details
2.9.2 Merck & Co. (MSD) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Merck & Co. (MSD) SWOT Analysis
2.9.4 Merck & Co. (MSD) Product and Services
2.9.5 Merck & Co. (MSD) Medication Revenue, Gross Margin and Market Share (2018-2019)
2.10 GlaxoSmithKline (GSK)
2.10.1 GlaxoSmithKline (GSK) Details
2.10.2 GlaxoSmithKline (GSK) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 GlaxoSmithKline (GSK) SWOT Analysis
2.10.4 GlaxoSmithKline (GSK) Product and Services
2.10.5 GlaxoSmithKline (GSK) Medication Revenue, Gross Margin and Market Share (2018-2019)
2.11 Bayer
2.11.1 Bayer Details
2.11.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Bayer SWOT Analysis
2.11.4 Bayer Product and Services
2.11.5 Bayer Medication Revenue, Gross Margin and Market Share (2018-2019)
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Takeda SWOT Analysis
2.12.4 Takeda Product and Services
2.12.5 Takeda Medication Revenue, Gross Margin and Market Share (2018-2019)
2.13 AstraZeneca
2.13.1 AstraZeneca Details
2.13.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 AstraZeneca SWOT Analysis
2.13.4 AstraZeneca Product and Services
2.13.5 AstraZeneca Medication Revenue, Gross Margin and Market Share (2018-2019)
2.14 Takeda
2.14.1 Takeda Details
2.14.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Takeda SWOT Analysis
2.14.4 Takeda Product and Services
2.14.5 Takeda Medication Revenue, Gross Margin and Market Share (2018-2019)
2.15 Novo Nordisk
2.15.1 Novo Nordisk Details
2.15.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Novo Nordisk SWOT Analysis
2.15.4 Novo Nordisk Product and Services
2.15.5 Novo Nordisk Medication Revenue, Gross Margin and Market Share (2018-2019)
2.16 Teva
2.16.1 Teva Details
2.16.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Teva SWOT Analysis
2.16.4 Teva Product and Services
2.16.5 Teva Medication Revenue, Gross Margin and Market Share (2018-2019)
2.17 Bristol-Myers Squibb
2.17.1 Bristol-Myers Squibb Details
2.17.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Bristol-Myers Squibb SWOT Analysis
2.17.4 Bristol-Myers Squibb Product and Services
2.17.5 Bristol-Myers Squibb Medication Revenue, Gross Margin and Market Share (2018-2019)
2.18 Boehringer Ingelheim
2.18.1 Boehringer Ingelheim Details
2.18.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Boehringer Ingelheim SWOT Analysis
2.18.4 Boehringer Ingelheim Product and Services
2.18.3 Boehringer Ingelheim Medication Revenue, Gross Margin and Market Share (2018-2019)
2.19 Allergan
2.19.1 Allergan Details
2.19.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Allergan SWOT Analysis
2.19.4 Allergan Product and Services
2.19.5 Allergan Medication Revenue, Gross Margin and Market Share (2018-2019)
2.20 Eli Lilly
2.20.1 Eli Lilly Details
2.20.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Eli Lilly SWOT Analysis
2.20.4 Eli Lilly Product and Services
2.20.5 Eli Lilly Medication Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Medication Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Medication Players Market Share
3.2.2 Top 10 Medication Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Medication Revenue and Market Share by Regions
4.2 North America Medication Revenue and Growth Rate (2015-2020)
4.3 Europe Medication Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Medication Revenue and Growth Rate (2015-2020)
4.5 South America Medication Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Medication Revenue and Growth Rate (2015-2020)
5 North America Medication Revenue by Countries
5.1 North America Medication Revenue by Countries (2015-2020)
5.2 USA Medication Revenue and Growth Rate (2015-2020)
5.3 Canada Medication Revenue and Growth Rate (2015-2020)
5.4 Mexico Medication Revenue and Growth Rate (2015-2020)
6 Europe Medication Revenue by Countries
6.1 Europe Medication Revenue by Countries (2015-2020)
6.2 Germany Medication Revenue and Growth Rate (2015-2020)
6.3 UK Medication Revenue and Growth Rate (2015-2020)
6.4 France Medication Revenue and Growth Rate (2015-2020)
6.5 Russia Medication Revenue and Growth Rate (2015-2020)
6.6 Italy Medication Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Medication Revenue by Countries
7.1 Asia-Pacific Medication Revenue by Countries (2015-2020)
7.2 China Medication Revenue and Growth Rate (2015-2020)
7.3 Japan Medication Revenue and Growth Rate (2015-2020)
7.4 Korea Medication Revenue and Growth Rate (2015-2020)
7.5 India Medication Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Medication Revenue and Growth Rate (2015-2020)
8 South America Medication Revenue by Countries
8.1 South America Medication Revenue by Countries (2015-2020)
8.2 Brazil Medication Revenue and Growth Rate (2015-2020)
8.3 Argentina Medication Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Medication by Countries
9.1 Middle East & Africa Medication Revenue by Countries (2015-2020)
9.2 Saudi Arabia Medication Revenue and Growth Rate (2015-2020)
9.3 UAE Medication Revenue and Growth Rate (2015-2020)
9.4 Egypt Medication Revenue and Growth Rate (2015-2020)
9.5 South Africa Medication Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Medication Revenue and Market Share by Type (2015-2020)
10.2 Global Medication Market Forecast by Type (2019-2024)
10.3 Brand Drugs Revenue Growth Rate (2015-2025)
10.4 Generic Drug Revenue Growth Rate (2015-2025)
11 Global Medication Market Segment by Application
11.1 Global Medication Revenue Market Share by Application (2015-2020)
11.2 Medication Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Medication Market Size Forecast (2021-2025)
12.1 Global Medication Market Size Forecast (2021-2025)
12.2 Global Medication Market Forecast by Regions (2021-2025)
12.3 North America Medication Revenue Market Forecast (2021-2025)
12.4 Europe Medication Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Medication Revenue Market Forecast (2021-2025)
12.6 South America Medication Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Medication Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Medication Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Medication by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Medication Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Medication Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Medication Major Business
Table 7. Pfizer Medication Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Medication Product and Solutions
Table 10. Pfizer Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Gilead Sciences Corporate Information, Location and Competitors
Table 12. Gilead Sciences Medication Major Business
Table 13. Gilead Sciences Medication Total Revenue (USD Million) (2018-2019)
Table 14. Gilead Sciences SWOT Analysis
Table 15. Gilead Sciences Medication Product and Solutions
Table 16. Gilead Sciences Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Johnson & Johnson Corporate Information, Location and Competitors
Table 18. Johnson & Johnson Medication Major Business
Table 19. Johnson & Johnson Medication Total Revenue (USD Million) (2017-2018)
Table 20. Johnson & Johnson SWOT Analysis
Table 21. Johnson & Johnson Medication Product and Solutions
Table 22. Johnson & Johnson Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Corporate Information, Location and Competitors
Table 24. Roche Medication Major Business
Table 25. Roche Medication Total Revenue (USD Million) (2017-2018)
Table 26. Roche SWOT Analysis
Table 27. Roche Medication Product and Solutions
Table 28. Roche Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. AbbVie Corporate Information, Location and Competitors
Table 30. AbbVie Medication Major Business
Table 31. AbbVie Medication Total Revenue (USD Million) (2017-2018)
Table 32. AbbVie SWOT Analysis
Table 33. AbbVie Medication Product and Solutions
Table 34. AbbVie Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Sanofi Corporate Information, Location and Competitors
Table 36. Sanofi Medication Major Business
Table 37. Sanofi Medication Total Revenue (USD Million) (2017-2018)
Table 38. Sanofi SWOT Analysis
Table 39. Sanofi Medication Product and Solutions
Table 40. Sanofi Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Amgen Corporate Information, Location and Competitors
Table 42. Amgen Medication Major Business
Table 43. Amgen Medication Total Revenue (USD Million) (2017-2018)
Table 44. Amgen SWOT Analysis
Table 45. Amgen Medication Product and Solutions
Table 46. Amgen Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Novartis Corporate Information, Location and Competitors
Table 48. Novartis Medication Major Business
Table 49. Novartis Medication Total Revenue (USD Million) (2017-2018)
Table 50. Novartis SWOT Analysis
Table 51. Novartis Medication Product and Solutions
Table 52. Novartis Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Merck & Co. (MSD) Corporate Information, Location and Competitors
Table 54. Merck & Co. (MSD) Medication Major Business
Table 55. Merck & Co. (MSD) Medication Total Revenue (USD Million) (2017-2018)
Table 56. Merck & Co. (MSD) SWOT Analysis
Table 57. Merck & Co. (MSD) Medication Product and Solutions
Table 58. Merck & Co. (MSD) Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. GlaxoSmithKline (GSK) Corporate Information, Location and Competitors
Table 60. GlaxoSmithKline (GSK) Medication Major Business
Table 61. GlaxoSmithKline (GSK) Medication Total Revenue (USD Million) (2017-2018)
Table 62. GlaxoSmithKline (GSK) SWOT Analysis
Table 63. GlaxoSmithKline (GSK) Medication Product and Solutions
Table 64. GlaxoSmithKline (GSK) Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Bayer Corporate Information, Location and Competitors
Table 66. Bayer Medication Major Business
Table 67. Bayer Medication Total Revenue (USD Million) (2017-2018)
Table 68. Bayer SWOT Analysis
Table 69. Bayer Medication Product and Solutions
Table 70. Bayer Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Takeda Corporate Information, Location and Competitors
Table 72. Takeda Medication Major Business
Table 73. Takeda Medication Total Revenue (USD Million) (2017-2018)
Table 74. Takeda SWOT Analysis
Table 75. Takeda Medication Product and Solutions
Table 76. Takeda Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. AstraZeneca Corporate Information, Location and Competitors
Table 78. AstraZeneca Medication Major Business
Table 79. AstraZeneca Medication Total Revenue (USD Million) (2017-2018)
Table 80. AstraZeneca SWOT Analysis
Table 81. AstraZeneca Medication Product and Solutions
Table 82. AstraZeneca Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Takeda Corporate Information, Location and Competitors
Table 84. Takeda Medication Major Business
Table 85. Takeda Medication Total Revenue (USD Million) (2017-2018)
Table 86. Takeda SWOT Analysis
Table 87. Takeda Medication Product and Solutions
Table 88. Takeda Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Novo Nordisk Corporate Information, Location and Competitors
Table 90. Novo Nordisk Medication Major Business
Table 91. Novo Nordisk Medication Total Revenue (USD Million) (2017-2018)
Table 92. Novo Nordisk SWOT Analysis
Table 93. Novo Nordisk Medication Product and Solutions
Table 94. Novo Nordisk Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Teva Corporate Information, Location and Competitors
Table 96. Teva Medication Major Business
Table 97. Teva Medication Total Revenue (USD Million) (2017-2018)
Table 98. Teva SWOT Analysis
Table 99. Teva Medication Product and Solutions
Table 100. Teva Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 102. Bristol-Myers Squibb Medication Major Business
Table 103. Bristol-Myers Squibb Medication Total Revenue (USD Million) (2017-2018)
Table 104. Bristol-Myers Squibb SWOT Analysis
Table 105. Bristol-Myers Squibb Medication Product and Solutions
Table 106. Bristol-Myers Squibb Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Boehringer Ingelheim Medication Type and Application
Table 108. Boehringer Ingelheim Medication Major Business
Table 109. Boehringer Ingelheim Medication Total Revenue (USD Million) (2017-2018)
Table 110. Boehringer Ingelheim SWOT Analysis
Table 111. Boehringer Ingelheim Medication Product and Solutions
Table 112. Boehringer Ingelheim Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Allergan Corporate Information, Location and Competitors
Table 114. Allergan Medication Major Business
Table 115. Allergan Medication Total Revenue (USD Million) (2017-2018)
Table 116. Allergan SWOT Analysis
Table 117. Allergan Medication Product and Solutions
Table 118. Allergan Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Eli Lilly Corporate Information, Location and Competitors
Table 120. Eli Lilly Medication Major Business
Table 121. Eli Lilly Medication Total Revenue (USD Million) (2017-2018)
Table 122. Eli Lilly SWOT Analysis
Table 123. Eli Lilly Medication Product and Solutions
Table 124. Eli Lilly Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Global Medication Revenue (Million USD) by Players (2015-2020)
Table 126. Global Medication Revenue Share by Players (2015-2020)
Table 127. Global Medication Revenue (Million USD) by Regions (2015-2020)
Table 128. Global Medication Revenue Market Share by Regions (2015-2020)
Table 129. North America Medication Revenue by Countries (2015-2020)
Table 130. North America Medication Revenue Market Share by Countries (2015-2020)
Table 131. Europe Medication Revenue (Million USD) by Countries (2015-2020)
Table 132. Asia-Pacific Medication Revenue (Million USD) by Countries (2015-2020)
Table 133. South America Medication Revenue by Countries (2015-2020)
Table 134. South America Medication Revenue Market Share by Countries (2015-2020)
Table 135. Middle East and Africa Medication Revenue (Million USD) by Countries (2015-2020)
Table 136. Middle East and Africa Medication Revenue Market Share by Countries (2015-2020)
Table 137. Global Medication Revenue (Million USD) by Type (2015-2020)
Table 138. Global Medication Revenue Share by Type (2015-2020)
Table 139. Global Medication Revenue Forecast by Type (2021-2025)
Table 140. Global Medication Revenue by Application (2015-2020)
Table 141. Global Medication Revenue Share by Application (2015-2020)
Table 142. Global Medication Revenue Forecast by Application (2021-2025)
Table 143. Global Medication Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Medication Picture
Figure 2. Global Medication Revenue Market Share by Type in 2019
Figure 3. Brand Drugs Picture
Figure 4. Generic Drug Picture
Figure 5. Medication Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Other Picture
Figure 9. Global Medication Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Medication Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Medication Revenue Market Share in 2019
Figure 18. Global Top 10 Players Medication Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Medication Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Medication Revenue Market Share by Regions (2015-2020)
Figure 22. Global Medication Revenue Market Share by Regions in 2018
Figure 23. North America Medication Revenue and Growth Rate (2015-2020)
Figure 24. Europe Medication Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Medication Revenue and Growth Rate (2015-2020)
Figure 26. South America Medication Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Medication Revenue and Growth Rate (2015-2020)
Figure 28. North America Medication Revenue Market Share by Countries (2015-2020)
Figure 29. North America Medication Revenue Market Share by Countries in 2019
Figure 30. USA Medication Revenue and Growth Rate (2015-2020)
Figure 31. Canada Medication Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Medication Revenue and Growth Rate (2015-2020)
Figure 33. Europe Medication Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Medication Revenue Market Share by Countries in 2019
Figure 35. Germany Medication Revenue and Growth Rate (2015-2020)
Figure 36. UK Medication Revenue and Growth Rate (2015-2020)
Figure 37. France Medication Revenue and Growth Rate (2015-2020)
Figure 38. Russia Medication Revenue and Growth Rate (2015-2020)
Figure 39. Italy Medication Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Medication Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Medication Revenue Market Share by Countries in 2019
Figure 42. China Medication Revenue and Growth Rate (2015-2020)
Figure 43. Japan Medication Revenue and Growth Rate (2015-2020)
Figure 44. Korea Medication Revenue and Growth Rate (2015-2020)
Figure 45. India Medication Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Medication Revenue and Growth Rate (2015-2020)
Figure 47. South America Medication Revenue Market Share by Countries (2015-2020)
Figure 48. South America Medication Revenue Market Share by Countries in 2019
Figure 49. Brazil Medication Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Medication Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Medication Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Medication Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Medication Revenue and Growth Rate (2015-2020)
Figure 54. UAE Medication Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Medication Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Medication Revenue and Growth Rate (2015-2020)
Figure 57. Global Medication Revenue Share by Type (2015-2020)
Figure 58. Global Medication Revenue Share by Type in 2019
Figure 59. Global Medication Market Share Forecast by Type (2021-2025)
Figure 60. Global Brand Drugs Revenue Growth Rate (2015-2020)
Figure 61. Global Generic Drug Revenue Growth Rate (2015-2020)
Figure 62. Global Medication Revenue Share by Application (2015-2020)
Figure 63. Global Medication Revenue Share by Application in 2019
Figure 64. Global Medication Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospital Revenue Growth Rate (2015-2020)
Figure 66. Global Clinic Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Medication Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Medication Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Medication Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Medication Revenue Market Forecast (2021-2025)
Figure 72. Europe Medication Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Medication Revenue Market Forecast (2021-2025)
Figure 74. South America Medication Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Medication Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
薬物療法管理の世界市場（～2026年） Medication therapy management, generally called medicine use review in the United kingdom, is a service provided typically by pharmacists that aims to improve outcomes by helping people to better understand their health conditions and the medications used to manage them. This includes providing educ…- 自己管理薬の世界市場（～2026年） Self-administration is, in its medical sense, the process of a subject administering a pharmacological substance to themself. A clinical example of this is the subcutaneous "self-injection" of insulin by a diabetic patient. By distribution channel, the hospital pharmacies segment is expected to repr…
- 抗マラリア薬の世界市場（～2026年） Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. viva…
- フレーバー獣医用医薬品の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Flavored Veterinary Medication market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- ペット用医薬品の世界市場（～2026年） Market Analysis and Insights: Global Pet Medication Market The global Pet Medication market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pet Medication Scope and Market Size Pet Medication market is segmented by Type, and …